Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV000023864 | SCV002792477 | pathogenic | Amelogenesis imperfecta type 1G | 2022-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002513210 | SCV003442511 | pathogenic | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg136*) in the FAM20A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAM20A are known to be pathogenic (PMID: 21990045, 23434854). This variant is present in population databases (rs144411158, gnomAD 0.04%). This premature translational stop signal has been observed in individual(s) with amelogenesis imperfecta and/or enamel-renal syndrome (PMID: 21549343, 23434854, 28086997). ClinVar contains an entry for this variant (Variation ID: 30879). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV002513210 | SCV003853042 | pathogenic | not provided | 2022-09-27 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 28086997, 18597613, 28694781, 23468644, 21549343, 23434854) |
OMIM | RCV000023864 | SCV000045155 | pathogenic | Amelogenesis imperfecta type 1G | 2012-01-01 | no assertion criteria provided | literature only |